Linda Beth Siegel, MD

Stacey E. Rosen, MD is the senior vice president for the Katz Institute for Women's Health, the Partners Council Professor of Women's Health and Professor of Cardiology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Rosen is a leading expert in the field of cardiovascular disease in women and oversees women's health services at Northwell Health with a focus on the elimination of healthcare disparities through comprehensive clinical programs, gender-based research, community partnerships and education.Dr. Rosen has been a practicing cardiologist for over 30 years and co-authored the new book, Heart Smarter for Women: Six Weeks to a Healthier Heart published in 2022. She also co-produced her first documentary titled "Ms. Diagnosed" which premiered at the Cinequest film festival in 2020.A longtime volunteer for the American Heart Association (AHA), she has served in leadership roles at the local, regional and national level. In 2018, she received the AHA's Women in Cardiology Mentoring Award and in 2021, she received the AHA's Physician of the Year Award. Dr. Rosen is a Fellow of the American College of Cardiology, the American College of Physicians, and the AHA. Dr. Rosen, a native Long Islander, is a graduate of the six-year medical program at Boston University School of Medicine (cum laude). Dr. Rosen completed training in Internal Medicine at Montefiore Medical Center in the Bronx, including an additional year as Chief Resident. She completed a fellowship in Cardiovascular Disease at The New York Hospital-Cornell University Medical College, which included advanced training in echocardiography.

Located in New Hyde Park, NY, Bradley Jason Kaufman MD is a distinguished medical practice offering a range of specialized healthcare services to patients in the area. Their dedicated team of professionals provides top-notch medical care, including primary care, advanced surgical treatments, and diagnostics, ensuring comprehensive and personalized healthcare solutions for all patients. Bradley Jason Kaufman MD focuses on delivering quality healthcare services while actively engaging in medical research, innovation, and community health initiatives to enhance patient care and promote well-being throughout the community. With a commitment to excellence, Bradley Jason Kaufman MD strives to uphold the highest standards of patient care by leveraging their expertise in healthcare to deliver exceptional medical services. Their unwavering dedication to improving healthcare outcomes is evident through their involvement in developing new technologies, participating in clinical trials, and fostering meaningful partnerships within the healthcare industry. Patients can trust Bradley Jason Kaufman MD to provide reliable and compassionate healthcare that prioritizes their well-being and ensures a positive healthcare experience. Generated using this brand's available information

I am a pediatric hematologist/oncologist who specializes in stem cell transplantation and cellular therapy. I graduated from the Upstate Medical University, completed a residency in pediatrics at the Schneider Children's Hospital, served as Chief Resident of Pediatrics at the Schneider Children's Hospital, and then completed my training with a fellowship in pediatric hematology / oncology at the Children s Hospital of Philadelphia. During my fellowship, I concurrently spent 3 years in the laboratory researching cellular immunotherapy for acute lymphoblastic leukemia, while also pursuing a clinical interest in the late effects of childhood cancer treatment. In 2008 I came to the Cohen Children s Medical Center to found Survivors Facing Forward, a long-term follow-up program to provide care to survivors of childhood cancer and stem cell transplantation. Since 2008, the program has grown to follow nearly 1,000 survivors of childhood cancer and has been a fertile source for clinical research. In 2021 I assumed leadership of the stem cell transplantation and cellular therapy program at Cohen Children's Medical Center, where I am the Transplant Center Medial Director and Marrow Collection Facility Director. Our transplant center participates in national and international cooperative group studies in the use of stem cell transplantation and cellular therapy to treat cancers, bone marrow failure syndromes, immune deficiencies and hemoglobinopathies (sickle cell disease and thalassemia). Notably, we are one of a very limited number of Qualified Treatment Centers (QTC) for Zynteglo , an FDA approved gene therapy for transfusion dependent thalassemia, and are in the process of being named a QTC for gene therapy products recently FDA approved to cure sickle cell disease.